Similar articles

• [Influence of Na supplement and limitation on blood PRA, AII, ALD and renal function in patients with liver cirrhosis].

  Gu XB, Chen HK, Zhu YF, Pei H, Liu XY. Gu XB, et al. Zhonghua Gan Zang Bing Za Zhi. 2004 Jun;12(6):370. Zhonghua Gan Zang Bing Za Zhi. 2004. PMID: 15225438 Clinical Trial. Chinese. No abstract available.
• Renal failure in advanced liver disease.

  Baldus WP. Baldus WP. Prog Liver Dis. 1972;4:251-67. Prog Liver Dis. 1972. PMID: 4347066 Review. No abstract available.
• [Hepatorenal syndrome. Clinical and pathogenetic aspects and therapeutic approach].

  Marmo R, Persico M, Costume A, Bronzino P, Del Vecchio E, Gentile S, Porcellini M. Marmo R, et al. Clin Ter. 1984 Dec 15;111(5):443-9. Clin Ter. 1984. PMID: 6151436 Review. Italian. No abstract available.
• [Renal dysfunction in liver diseases].

  Rychalska-Glanc B. Rychalska-Glanc B. Przegl Epidemiol. 1975;29(2):229-33. Przegl Epidemiol. 1975. PMID: 1096246 Review. Polish. No abstract available.
• Hepatorenal syndrome. A review.

  Altman KA. Altman KA. Am J Gastroenterol. 1968 May;49(5):436-9. Am J Gastroenterol. 1968. PMID: 4297522 Review. No abstract available.